Matches in Nanopublications for { ?s ?p "DDI between Pantoprazole and Dabigatran etexilate - Proton pump inhibitors may decrease the bioavailability of dabigatran by 28% and increase inter-patient pharmacokinetic variability, especially in females. However, dose adjustment is not required. [drugbank_resource:DB00213_DB06695]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00213_DB06695 label "DDI between Pantoprazole and Dabigatran etexilate - Proton pump inhibitors may decrease the bioavailability of dabigatran by 28% and increase inter-patient pharmacokinetic variability, especially in females. However, dose adjustment is not required. [drugbank_resource:DB00213_DB06695]" assertion.